Skip to main content
. Author manuscript; available in PMC: 2017 Feb 19.
Published in final edited form as: Adv Exp Med Biol. 2016;916:169–197. doi: 10.1007/978-3-319-30654-4_8

Table 1.

Frequent epigenetic marks which are deregulated in cancers

Deregulated mark Change in cancer Modifier Associated with References
DNA methylation Regional hypermethylation DNMT1, DNMT3, UHRF1a Gene repression Herman et al. (1995) [98], Ai et al. (2006) [40], Bae et al. (2004) [41], Kornegoo et al. (2012) [99], Roll et al. (2013) [43], Zou et al. (2009) [100]
Global hypomethylation Genomic instability Bedford and van Helden (1987) [101], Cadieux et al. (2006) [102], Feinberg and Vogelstein (1983) [74], Fraga et al. (2005) [103], Mudbhary et al. (2014) [5], Rauch et al. (2008) [104]
Activation of retrotransposons Jackson-Grusby et al. (2001) [105], Howard et al. (2007) [106], Minoguchi and Iba (2008) [107]
H3K9me3 Hypermethylation G9a, SETDB1, SUV39H1 Increased gene repression Frigola et al. (2006) [108], Nguyen et al. (2002) [109]
H3k27me2–me3 Hypermethylation EZH1, EZH2 DNA hypermethylation Chinaranagari et al. (2014) [110], Ohm et al. (2007) [111], Popovic et al. (2014) [112], Schlesinger et al. (2007) [113]
H3K4me3 Hypomethylation MLL4 Gene repression Kang et al. (2015) [114], Nguyen et al. (2002) [109], Lee et al. (2013) [115]

List of common epigenetic marks and their analogous regulators are shown in relation to reported changes in chromatin or gene expression resulting from their misregulation

a

Although it does not modify the DNA methylome, UHRF1 is an essential necessary component of the DNMT1 complex